Description
Retatrutide 20mg
Retatrutide is an investigational triple receptor agonist studied in laboratory and clinical research involving GLP-1, GIP, and glucagon receptor pathways.
Research Areas
- GLP-1 receptor signaling research
- GIP receptor signaling research
- Glucagon receptor signaling research
- Multi-receptor agonism research
- Metabolic pathway research
- Endocrine signaling research
Research Status
Retatrutide is an investigational compound under clinical evaluation and is not an approved therapeutic product.
Storage
Store refrigerated at 2–8°C (36–46°F).
Do not freeze.
Protect from heat and direct sunlight.
Warning
For research use only.
Not for human consumption.
Keep out of reach of children.
Reviews
There are no reviews yet.